Lou Silverman - 12 May 2025 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Reporting relationship: Director
Issuer ticker: STAA
Reported as of: 12 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 May 2025, 18:04:36 UTC
Prior SEC filing: 29 Apr 2025
Next SEC filing: 03 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Nathaniel Sisitsky as attorney-in-fact for Louis E. Silverman

Key filing fact

Lou Silverman filed Form 4 for STAAR SURGICAL CO (STAA) on 13 May 2025.

Key facts

This page summarizes Lou Silverman's Form 4 filing for STAAR SURGICAL CO (STAA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 May 2025, 18:04.

Change

Previous filing in this sequence was filed on 29 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001249935 Primary reporting owner

SILVERMAN LOU

Relationship: Director
Address: 25510 COMMERCENTRE DRIVE, LAKE FOREST
Signature: /s/ Nathaniel Sisitsky as attorney-in-fact for Louis E. Silverman
Signature date: 13 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STAA transaction Derivative

Common Stock Options

Award

Transaction value: $0
Shares: +2,440
Change %
Price: $0.000000
Shares after: 2,440
Date: 12 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,440
Exercise price: $20.27
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects options to purchase common stock granted on May 12, 2025, pursuant to the Corporation's standard non-employee director equity compensation program, pro-rated for the remaining portion of the 2024-2025 term. This award vests in full on June 18, 2025, the date of the Corporation's 2025 Annual Meeting of Shareholders.